Precigen (PGEN) Assets (2012 - 2026)
Precigen (PGEN) posted quarterly Assets of $138.6 million for Q1 2026, up 7.64% year-over-year from $128.8 million in Q1 2025, and down 10.85% quarter-over-quarter from $155.5 million in Q4 2025.
Precigen (PGEN) Assets (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Assets for 15 consecutive years, with $138.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 7.64% year-over-year to $138.6 million; the TTM figure through Mar 2026 stood at $138.6 million (up 7.64% YoY), while the FY2025 annual figure was $155.5 million, up 7.05% from the prior year.
- Assets retreated to $138.6 million in Q1 2026 per PGEN's latest filing, from $155.5 million in the prior quarter.
- Across five years, Assets topped out at $335.6 million in Q1 2022 and bottomed at $73.2 million in Q2 2024.
- Historically, Assets has averaged $179.7 million across 5 years, with a median of $155.5 million in 2025.
- Annual changes were most pronounced in 2024 — Assets sank 64.75% — and 2025, when it soared 105.17%.
- Precigen's Assets stood at $216.0 million in 2022, then slumped by 30.07% to $151.0 million in 2023, then dropped by 3.82% to $145.3 million in 2024, then advanced by 7.05% to $155.5 million in 2025, then retreated by 10.85% to $138.6 million in 2026.
- Business Quant data shows PGEN's Assets at $138.6 million in Q1 2026, $155.5 million in Q4 2025, and $171.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 170.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 170.30 Mn |
| Mar 31, 2026 | 138.63 Mn |
| Dec 31, 2025 | 155.51 Mn |
| Sep 30, 2025 | 171.26 Mn |
| Jun 30, 2025 | 101.90 Mn |
| Mar 31, 2025 | 128.79 Mn |
| Dec 31, 2024 | 145.27 Mn |
| Sep 30, 2024 | 83.47 Mn |
| Jun 30, 2024 | 73.16 Mn |
| Mar 31, 2024 | 134.85 Mn |
| Dec 31, 2023 | 151.04 Mn |
| Sep 30, 2023 | 190.69 Mn |
| Jun 30, 2023 | 207.53 Mn |
| Mar 31, 2023 | 241.55 Mn |
| Dec 31, 2022 | 215.98 Mn |
| Sep 30, 2022 | 259.25 Mn |
| Jun 30, 2022 | 321.22 Mn |
| Mar 31, 2022 | 335.57 Mn |
| Dec 31, 2021 | 359.86 Mn |
| Sep 30, 2021 | 376.90 Mn |